• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Genetic and Multiorgan Imaging Approach Reveals Heart–Brain Connections

Genetic and Multiorgan Imaging Approach Reveals Heart–Brain Connections

by Zahraa Chorghay, PhD | Jun 30, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Diagnostics Pipeline: First FDA Approval of CRISPR Therapy Possible This Year

The Diagnostics Pipeline: First FDA Approval of CRISPR Therapy Possible This Year

by Glenn S. Demby | Jun 30, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Making Complete Genome Sequencing Affordable, Accessible

Making Complete Genome Sequencing Affordable, Accessible

by Swathi Kodaikal, MSc | Jun 30, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Smartphone App Encourages People to Seek Therapy for Heart Disease

New Smartphone App Encourages People to Seek Therapy for Heart Disease

by Rachel Muenz | Mar 18, 2022 | Articles, News, Open Content

Smartphone apps can already help manage many aspects of our health, from tracking physical activity to suggesting healthy eating options to monitoring heart rate. Now, a new app has been developed that predicts an individual’s genetic risk for coronary artery disease...
MRI May Lower Breast Cancer Deaths from Variants in 3 Genes

MRI May Lower Breast Cancer Deaths from Variants in 3 Genes

by University of Washington School of Medicine | Feb 18, 2022 | Articles, News

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50 percent among women who carry certain genetic changes in three genes, according to a comparative modeling analysis published Feb. 17, 2022, in JAMA Oncology. The...
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com